Loading...
Symbols:
Loading...
Symbols:
King Pharmaceuticals Inc. (KG)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on King Pharmaceuticals Inc. (KG)
45 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on KG
- Mike Havrilla(6)
- Bespoke Investment Group(6)
- Centient Biotech Investor(4)
- Andrew Wilkinson(4)
- Aaron F. Barkoff(3)
Most popular authors
(tracked in watchlists)
- Bespoke Investment Group(572)
- SA Editor Eli Hoffmann(386)
- Mike Stathis (338)
- Andrew Wilkinson(333)
- Stockerblog (167)
Most commented on authors
- Mike Stathis (36)
- SA Editor Eli Hoffmann(25)
- Alan Brochstein(23)
- Bespoke Investment Group(13)
- BioLogic Research(9)
- Ten Bright Ways to Invest in Tennessee
- Stocks Offering 'Healthy' Returns
- Top Ten Magic Formula Stocks with Strong Relative Strength
- Full FDA Calendar for Remainder 2008
- Post-Election Stock Massacre
- S&P 500 Stocks Above 50-Day Moving Averages
- Backlog of Decisions Is Building at the FDA
- Wall Street Breakfast: Must-Know News
- Earnings Preview: King Pharmaceuticals
- 23 Stocks to Consider During Global Deleveraging
- FDA Watch: Painkillers on the Fall/Winter Agenda
- Animal Healthcare Biz Posts Loss, But Outpaces Healthcare ETFs
- Alpharma Rejects King Pharma's Offer; What Now?
- FDA Decision Calendar: Some Potentially Prominent Decisions in Early 2009
- Thursday Options Update: MS, STT, LM, NAL, GGP, PLD, KG, DO
- Friday Options Update: LEH, SCHW, AKAM, KG, APO, TGT, ORCL, KO
- Earnings Preview: King Pharmaceuticals
- Tuesday Options Outlook: CSCO, KG, IWO, HNT, SIRO, MGM, IWD, GTXI
- Acura' Acurox: A Revenue-Deterrent Formulation of Oxycodone
- Gannon On Investing's July 2008 Blogger Roundtable
- S&P 500 Stocks Furthest Above and Below Their 50-Day Moving Averages
- FDA Denies King Pharma's Citizen Petition on Altace; Approves Ramipril ANDAs
- King Pharmaceuticals Files Citizen Petition Relating to New Altace Patent
- Industries to Avoid, Industries to Buy
- Wall Street Breakfast: Must-Know News
- Thursday's Options Report: MRK, AZN, LEH, C, CCU, ORCL
- Healthcare Stocks Have Been Anything but Defensive
- Exiting My King Pharma Position with a Nice Gain
- China on Sale, Discounted Pharmaceuticals
- Stocks Furthest Above, Below Their 50-Day Moving Averages
- Aventis' Altace Patent Invalidated by Circuit Court
- Stocks With the Least Analyst Love
- Depomed: Unique Proprietary Technology Gives Its Products a Clear Advantage
- The Little Stock that Beats the Market: Joel Greenblatt's Winning Plan
- King Pharmaceuticals: A Healthy Way to Recover from the Selloff
- Biotechs Make Appearances in Best and Worst Lists of WSJ Review
- Top Picks for 2007 from JPMorgan HealthCare Analysts
- Boston Scientific Addresses Quality Issues at JPMorgan's HealthCare Conference
- Biotech Stocks Day-in-Review: Genentech Beats Estimates
- Fisher's Buyout Candidates
- Evaluating the Implosion in Neurocrine Biosciences (NBIX, DOVP, SEPR, KG)
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »